Advanced search
Publication Cover
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 16, 2003 - Issue 1
Submit an article Journal homepage
54
Views
1
CrossRef citations to date
0
Altmetric
Articles

Gary L. Davis, MD: A Conversation with the Editor

Gary L. DavisCorrespondence[email protected]
, MD
Pages 73-84 | Published online: 11 Dec 2017

GLD's Best Articles as Selected by Him

Original Articles

  • Davis GL, Czaja AJ. Current concepts in the diagnosis and management of hepatitis B surface antigen-positive chronic active hepatitis. J Clin Gastroenterol 1981;3: 381–388.
  • Czaja AJ, Davis GL. Hepatitis non A, non B. Manifestations and implications of acute and chronic disease. Mayo Clin Proc 1982;57: 639–652.
  • Davis GL, Czaja AJ, Baggenstoss AH, Taswell HF. Prognostic and therapeutic implications of extreme serum aminotransferase elevation in chronic active hepatitis. Mayo Clin Proc 1982;57: 303–309.
  • Kerlin P, Davis GL, McGill DB, Weiland LH, Adson MA, Sheedy PF II. Hepatic adenoma and focal nodular hyperplasia: clinical, pathologic, and radiologic features. Gastroenterology 1983;84 (5 Pt 1): 994–1002.
  • Davis GL, Hoofnagle JH, Waggoner JG. Spontaneous reactivation of chronic hepatitis B virus infection. Gastroenterology 1984;86: 230–235.
  • Davis GL, Hoofnagle JH, Waggoner JG. Acute type A hepatitis during chronic hepatitis B virus infection: association of depressed hepatitis B virus replication with appearance of endogenous alpha interferon. J Med Virol 1984;14: 141–147.
  • Davis GL, Czaja AJ, Taswell HF, Ludwig J, Go VL. Hepatitis B virus replication in steroid-treated severe HBsAg-positive chronic active hepatitis. Dig Dis Sci 1985;30: 97–103.
  • Jicha DL, Davis GL, Peters MG, Hoofnagle JH, Jones EA. Effects of recombinant human leukocyte interferon treatment of endogenous interferon production in patients with chronic type-B hepatitis. J Interferon Res 1986;6: 13–20.
  • Davis GL, Hoofnagle JH. Interferon in viral hepatitis: role in pathogenesis and treatment. Hepatology 1986;6: 1038–1041.
  • Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer HC Jr, Perrillo RP, Carey W, Jacobson IM, Payne J, Dienstag JL, et al. Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial. Hepatitis Interventional Therapy Group. N Engl J Med 1989;321: 1501–1506.
  • Davis GL. Interferon treatment of viral hepatitis in immunocompromised patients. Semin Liver Dis 1989;9: 267–272.
  • Davis GL. Genomic variation of hepatitis C virus: clues to clinical variation? Gastroenterology 1992;103: 344–346.
  • Lau JY, Davis GL, Kniffen J, Qian KP, Urdea MS, Chan CS, Mizokami M, Neuwald PD, Wilber JC. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 1993;341: 1501–1504.
  • Lau JY, Davis GL, Brunson ME, Qian KP, Lin HJ, Quan S, DiNello R, Polito AJ, Scornik JC. Hepatitis C virus infection in kidney transplant recipients. Hepatology 1993;18: 1027–1031.
  • Lau JY, Mizokami M, Ohno T, Diamond DA, Kniffen J, Davis GL. Discrepancy between biochemical and virological responses to interferon-alpha in chronic hepatitis C. Lancet 1993;342: 1208–1209.
  • Lau JY, Davis GL. Detection of hepatitis C virus RNA genome in liver tissue by nonisotopic in situ hybridization. J Med Virol 1994;42: 268–271.
  • Davis GL, Lau JY, Urdea MS, Neuwald PD, Wilber JC, Lindsay K, Perrillo RP, Albrecht J. Quantitative detection of hepatitis C virus RNA with a solid-phase signal amplification method: definition of optimal conditions for specimen collection and clinical application in interferon-treated patients. Hepatology 1994;19: 1337–1341.
  • Davis GL, Lindsay K, Albrecht J, Bodenheimer HC Jr, Balart LA, Perrillo RP, Dienstag JL, Tamburro C, Schiff ER, Carey W, et al. Clinical predictors of response to recombinant interferon-alpha treatment in patients with chronic non-A, non-B hepatitis (hepatitis C). The Hepatitis Interventional Therapy Group. J Viral Hepat 1994;1: 55–63.
  • Davis GL, Lau JY. Choice of appropriate end points of response to interferon therapy in chronic hepatitis C virus infection. J Hepatol 1995;22: 110–114.
  • Bennett WG, Inoue Y, Beck JR, Wong JB, Pauker SG, Davis GL. Estimates of the cost-effectiveness of a single course of interferon-alpha 2b in patients with histologically mild chronic hepatitis C. Ann Intern Med 1997;127: 855–865.
  • Lau JY, Davis GL, Prescott LE, Maertens G, Lindsay KL, Qian K, Mizokami M, Simmonds P. Distribution of hepatitis C virus genotypes determined by line probe assay in patients with chronic hepatitis C seen at tertiary referral centers in the United States. Hepatitis Interventional Therapy Group. Ann Intern Med 1996;124: 868–876.
  • Lau JY, Qian K, Detmer J, Collins ML, Orito E, Kolberg JA, Urdea MS, Mizokami M, Davis GL. Effect of interferon-alpha and ribavirin therapy on serum GB virus C/hepatitis G virus (GBV-C/HGV) RNA levels in patients chronically infected with hepatitis C virus and GBV-C/HGV. J Infect Dis 1997;176: 421–426.
  • Ros PR, Davis GL. The incidental focal liver lesion: photon, proton, or needle? Hepatology 1998;27: 1183–1190.
  • Davis GL, Beck JR, Farrell G, Poynard T. Prolonged treatment with interferon in patients with histologically mild chronic hepatitis C: a decision analysis. J Viral Hepat 1998;5: 313–321.
  • Davis GL, Esteban-Mur R, Rustgi V, Hoefs J, Gordon SC, Trepo C, Shiffman ML, Zeuzem S, Craxi A, Ling MH, Albrecht J. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group. N Engl J Med 1998;339: 1493–1499.
  • Poynard T, McHutchison J, Davis GL, Esteban-Mur R, Goodman Z, Bedossa P, Albrecht J. Impact of interferon alfa-2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis C. Hepatology 2000;32: 1131–1137.
  • Ware JE Jr, Bayliss MS, Mannocchia M, Davis GL. Health-related quality of life in chronic hepatitis C: impact of disease and treatment response. The Interventional Therapy Group. Hepatology 1999;30: 550–555.
  • Nelson DR, Lauwers GY, Lau JY, Davis GL. Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon nonresponders. Gastroenterology 2000;118: 655–660.
  • Davis GL, Rodrigue JR. Treatment of chronic hepatitis C in active drug users. N Engl J Med 2001;345: 215–217.
  • Nelson DR, Soldevila-Pico C, Reed A, Abdelmalek MF, Hemming AW, Van der Werf WJ, Howard R, Davis GL. Anti-interleukin-2 receptor therapy in combination with mycophenolate mofetil is associated with more severe hepatitis C recurrence after liver transplantation. Liver Transpl 2001;7: 1064–1070.

Book Chapters, Reviews, Proceedings, Monographs

  • Davis GL, Czaja AJ. Effects of surgery for portal hypertension on chronic active hepatitis. In Cohen S, Soloway R, eds. Contemporary Issues in Gastroenterology: Chronic Active Hepatitis. New York: Churchill Livingstone, 1982: 217–226.
  • Davis GL. Space-occupying lesions of the liver. In Taylor M, Gollan J, Wolfe MM, eds. Gastrointestinal Emergencies. Boston: W Wilkins, 1992: 319–338.
  • Davis GL. Hepatitis C virus. In Mandell GL, Douglas RG, Bennett JE, eds. Principles and Practice of Infectious Diseases: Update 10. New York: Churchill Livingstone, 1991: 3–11.
  • Davis GL, Lau JYN. Hepatitis C. In Haubrich W, Schaffner F, Berk J, eds. Bockus Gastroenterology. Philadelphia: WB Saunders, 1995: 2082–2114.
  • Lau JYN, Davis GL. Molecular biology of hepatitis B and C viruses. In Bittar EE, ed. Principles of Medical Biology. Amsterdam: JAI Press, 1997.
  • Abbitt PL, Davis GL. Space-occupying lesions of the liver. In Taylor M, Gollan J, Wolfe MM, eds. Gastrointestinal Emergencies, 2nd ed. Boston: W Wilkins, 1997: 435–464.
  • Davis GL. Chronic hepatitis. In Kaplowitz N, ed. Liver and Biliary Diseases, 2nd ed. Baltimore: Williams & Wilkins, 1996: 327–338.
  • Davis GL. Hepatitis C. In Schiff ER, Maddrey W, Sorrell M, eds. Schiff's Diseases of the Liver, 8th ed. Philadelphia: Lippincott Williams & Wilkins, 1998: 793–836.
  • Davis GL. Prevention and treatment of viral hepatitis. In Wolfe MM, ed. Therapy of Digestive Disorders: A Companion to Sleisenger and Fordtran's Gastrointestinal and Liver Disease. Philadelphia: WB Saunders, 1999: 289–306.
  • Davis GL, Nelson DR, Reyes GR. Future options for the management of hepatitis C. Semin Liver Dis 1999;19 Stuppl 1: 103–112.
  • Davis GL. Hepatitis C virus genotypes and quasispecies. Am J Med 1999;107 (6B): 21S–26S.
  • Davis GL. Current therapy for chronic hepatitis C. Gastroenterology 2000;118: S104–S114.
  • Davis GL. Hepatitis C. In Schiff ER, Maddrey W, Sorrell M, eds. Schiff's Diseases of the Liver, 9th ed. Philadelphia: Lippincott Williams & Wilkins, 2002 (in press).

Books

  • Davis GL, section ed. Therapy of Digestive Disorders: A Companion to Sleisenger and Fordtran's Gastrointestinal and Liver Disease. Philadelphia: WB Saunders, 1998.
  • Davis GL, guest ed. Clinics in Liver Disease, Vol 1 (3). Philadelphia: WB Saunders, 1997.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.